Biogen will soon extend its contract pharmacy restrictions to non-hospital covered entities, while Novartis will require hospitals to submit claims [...] …
Category: Pharma Industry
A federal judge’s recent ruling against West Virginia’s 340B contract pharmacy law advances the drug industry’s push to bring the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Contract pharmacy restrictions—and legislation to override them—dominated 340B policy discussions in statehouses and courtrooms across the country this year, as [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 119th Congress’ House Energy and Commerce (E&C) Committee—an influential panel with jurisdiction over the Medicaid and 340B programs—will feature [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Three manufacturers and a drug industry trade group dropped their lawsuits against Kansas’ 340B contract pharmacy access law after the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B Report [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In the first major legal setback for states pursuing contract pharmacy protections, a federal district judge ruled yesterday that West Virginia officials cannot enforce the state’s contract pharmacy access law while three drug industry legal challenges play out.
U.S. District
…
Emerging regulatory conflicts between the Inflation Reduction Act (IRA) and the 340B program may soon force policymakers to enact major [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
AbbVie’s latest move to extend certain 340B contract pharmacy restrictions to federal grantees also appears to target hospitals’ use of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A San Diego-based drugmaker recently notified 340B covered entities of manufacturing and drug code changes for an antibiotic used to [...] …